- Home
- CHRO vs LCFY Comparison
CHRO vs LCFY Comparison
Compare CHRO & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRO
- LCFY
- Stock Information
- Founded
- CHRO 2002
- LCFY 2009
- Country
- CHRO United States
- LCFY Australia
- Employees
- CHRO N/A
- LCFY N/A
- Industry
- CHRO
- LCFY
- Sector
- CHRO
- LCFY
- Exchange
- CHRO Nasdaq
- LCFY Nasdaq
- Market Cap
- CHRO 11.3M
- LCFY 9.9M
- IPO Year
- CHRO 2024
- LCFY 2022
- Fundamental
- Price
- CHRO $1.68
- LCFY $8.40
- Analyst Decision
- CHRO Strong Buy
- LCFY
- Analyst Count
- CHRO 1
- LCFY 0
- Target Price
- CHRO N/A
- LCFY N/A
- AVG Volume (30 Days)
- CHRO 104.9K
- LCFY 18.2K
- Earning Date
- CHRO 03-04-2025
- LCFY 04-01-2025
- Dividend Yield
- CHRO N/A
- LCFY N/A
- EPS Growth
- CHRO N/A
- LCFY N/A
- EPS
- CHRO N/A
- LCFY N/A
- Revenue
- CHRO N/A
- LCFY $2,668,385.00
- Revenue This Year
- CHRO N/A
- LCFY N/A
- Revenue Next Year
- CHRO N/A
- LCFY N/A
- P/E Ratio
- CHRO N/A
- LCFY N/A
- Revenue Growth
- CHRO N/A
- LCFY N/A
- 52 Week Low
- CHRO $0.45
- LCFY $2.20
- 52 Week High
- CHRO $4.84
- LCFY $11.23
- Technical
- Relative Strength Index (RSI)
- CHRO 50.49
- LCFY 57.38
- Support Level
- CHRO $1.59
- LCFY $5.80
- Resistance Level
- CHRO $1.99
- LCFY $8.95
- Average True Range (ATR)
- CHRO 0.29
- LCFY 0.63
- MACD
- CHRO -0.06
- LCFY 0.13
- Stochastic Oscillator
- CHRO 41.44
- LCFY 82.54
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.